Ionic liquids promote amyloid formation from α-synuclein

Analytical Biochemistry

Volumn 386, Issue 2, 2009, Pages 293-295

  Hwang, Heejin ^a   Choi, Hyunghun ^a   Kim, Hyun kyung ^a   Jo, Do Hyun ^a   Kim, T Doohun ^a  

^a Graduate School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEINS; IONIC LIQUIDS;

AMYLOID FIBRIL; AMYLOID FORMATION; IONIC LIQUID (ILS); PARKINSON'S DISEASE; SYNUCLEIN; THERAPEUTIC COMPOUNDS;

NEURODEGENERATIVE DISEASES;

ALPHA SYNUCLEIN; AMYLOID; IONIC LIQUID;

ARTICLE; CHEMICAL STRUCTURE; FLUORESCENCE; KINETICS; PRIORITY JOURNAL; ROOM TEMPERATURE;

EID: 59749085988     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.12.019     Document Type: Article

References (13)

1. O. von Bohlen und Halbach, Synucleins and their relationship to Parkinson's disease, Cell Tissue Res. 318 (2004) 163-174.
2. Lee F.J., and Liu F. Genetic factors involved in the pathogenesis of Parkinson's disease. Brain Res. Rev. 58 (2008) 354-364
3. Kim T.D., Paik S.R., and Yang C.H. Structural and functional implications of C-terminal regions of α-synuclein. Biochemistry 41 (2002) 13782-13790
4. Inamdar N., Arulmozhi D., Tandon A., and Bodhankar S. Parkinson's disease: Genetics and beyond. Curr. Neuropharmacol. 5 (2007) 99-113
5. Li W., West N., Colla E., Pletnikova O., Troncoso J.C., Marsh L., Dawson T.M., Jäkälä P., Hartmann T., Price D.L., and Lee M.K. Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc. Natl. Acad. Sci. USA 102 (2005) 2162-2167
6. Luk K.C., Mills I.P., Trojanowski J.Q., and Lee V.M.-Y. Interactions between Hsp70 and the hydrophobic core of α-synuclein inhibit fibril assembly. Biochemistry 47 (2008) 12614-12625
7. Amer D.A., Irvine G.B., and El-Agnaf O.M. Inhibitors of α-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders. Exp. Brain Res. 173 (2006) 223-233
8. Dufty B.M., Warner L.R., Hou S.T., Jiang S.X., Gomez-Isla T., Leenhouts K.M., Oxford J.T., Feany M.B., Masliah E., and Rohn T.T. Calpain-cleavage of α-synuclein: connecting proteolytic processing to disease-linked aggregation. Am. J. Pathol. 170 (2007) 1725-1738
9. Han X., and Armstrong D.W. Ionic liquids in separations. Acc. Chem. Res. 40 (2007) 1079-1086
10. Ahn M., Kim S., Kang M., Ryu Y., and Kim T.D. Chaperone-like activities of α-synuclein: α-synuclein assists enzyme activities of esterases. Biochem. Biophys. Res. Commun. 346 (2006) 1142-1149
11. Cole N.B., Murphy D.D., Lebowitz J., Di Noto L., Levine R.L., and Nussbaum R.L. Metal-catalyzed oxidation of α-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J. Biol. Chem. 280 (2005) 9678-9690
12. M. Bisaglia, S. Mammi, L. Bubacco, Structural insights on physiological functions and pathological effects of α-synuclein, FASEB J. (2008) doi:10.1096/fj.08-119784.
13. Schiesling C., Kieper N., Seidel K., and Krüger R. Familial Parkinson's disease genetics, clinical phenotype, and neuropathology in relation to the common sporadic form of the disease. Neuropathol. Appl. Neurobiol. 34 (2008) 255-271